Management of patients with liver derangement during the COVID-19 pandemic: an Asia-Pacific position statement
- 22 June 2020
- journal article
- review article
- Published by Elsevier BV in The Lancet Gastroenterology & Hepatology
- Vol. 5 (8), 776-787
- https://doi.org/10.1016/s2468-1253(20)30190-4
Abstract
No abstract availableThis publication has 75 references indexed in Scilit:
- Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 updateHepatology International, 2015
- Expanding consensus in portal hypertensionJournal of Hepatology, 2015
- Presentation and complications associated with cirrhosis of the liverCurrent Medical Research and Opinion, 2015
- Treatment cessation of entecavir in Asian patients with hepatitis B e antigen negative chronic hepatitis B: a multicentre prospective studyGut, 2014
- Standardization of nomenclature and causality assessment in drug-induced liver injury: Summary of a clinical research workshopJournal of Hepatology, 2010
- Intensive versus Conventional Glucose Control in Critically Ill PatientsThe New England Journal of Medicine, 2009
- Surveillance programme for hepatocellular carcinoma improves the survival of patients with chronic viral hepatitisLiver International, 2007
- Low Incidence of Severe Liver Events in HIV Patients With and Without Hepatitis C or B Coinfection Receiving Lopinavir/RitonavirHIV Research & Clinical Practice, 2006
- Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findingsThorax, 2004
- SARS-associated viral hepatitis caused by a novel coronavirus: Report of three casesJournal of Hepatology, 2004